Qualified Person for Pharmacovigilance (QPPV)

Including Local Person for Pharmacovigilance (LPPV)

QPPV Office

Appointing an experienced Qualified Person for Pharmacovigilance (QPPV), Local Person for Pharmacovigilance (LPPV), and deputy QPPV/LPPV can require considerable time and resources.

Although the requirements and responsibilities of a QPPV are specified in EU and UK legislation, LPPVs are subject to their own national legislation (e.g., the Graduated Plan Officer "Stufenplanbeauftragter" for Germany), which can also be daunting. As a global pharmacovigilance provider, ProPharma can advise you on the varied requirements for QPPVs and LPPVs to determine the services that will accommodate your business needs and ensure compliance with the pharmacovigilance legislation unique to each location. This will help you to determine your product launch strategy.

Based upon such strategy, ProPharma can provide you with appropriately qualified and experienced QPPVs, LPPVs, and deputies globally. We have a world-wide network of QPPVs and LPPVs to serve you with their expertise from Europe to Australia and in 100 countries.

Lab tech using a tablet device in a manufacturing facility
health-care-professional-meeting-virtually-with-another-healthcare-professional-ss-1936109602-650x425

Role of the EU QPPV

Every Marketing Authorization Holder (MAH) in Europe has an obligation to establish a pharmacovigilance (PV) system for the fulfillment of PV tasks for its products. When setting up a PV system in Europe, the MAH must appoint an EU QPPV to establish and maintain the MAH’s PV system. In addition to the establishment and oversight of the PV system, the QPPV also has several legislative responsibilities.

Responsibilities of the EU QPPV include:

  • Establish and maintain the MAH’s PV system
  • Monitor the safety of the MAH’s drug products
  • Coordinate actions to stay compliant with local legislation
  • Serve as the 24/7 point of contact for Competent Authorities

Role of an LPPV

In addition, many European and other countries legally require a Local Person for Pharmacovigilance (LPPV) at a country level who may report to the EU QPPV (e.g., for Germany a Graduated Plan Officer (GPO) or Stufenplanbeauftragter is required). Although the requirements and responsibilities of an EU QPPV are specified in EU legislation, LPPVs are subject to their own national legislation.

Some QPPVs may have their own network of LPPVs to help fulfill local requirements. As a global pharmacovigilance provider, ProPharma can advise you about the various important requirements for EU QPPVs and LPPVs, to ensure you have the right resources in place to fully comply with the regulations for your PV system in Europe.

Business and healthcare professionals smiling around charts

Understanding LPPV Regional Requirements

There are many differences between national legislations, so when you market a product in multiple European countries, you need to adhere to all the local specific requirements. Some examples are:

  • Timing: It is very important from what point in the product lifecycle an LPPV is required by the local health authority. This may be either from marketing authorisation, or from first launch of the product. Some countries do not require an LPPV at all.

  • Language and country: Many countries require their LPPV to speak the local language(s), and many require that the LPPV resides in the country. If the EU QPPV resides in the country, he or she may also act as an LPPV, provided that he or she speaks the local language, but there may be exceptions to this, so you cannot always assume you do not need an LPPV if you already have a QPPV in that country.
  • Education: Another difference is the requirements with regard to education. These range from none or not specified, to trained in PV, to medically qualified (basic medical training at academic level), to actually being a medical doctor or pharmacist.

  • Availability: Some countries require their LPPVs to have 24/7 availability for authorities, and some do not, but may require a 24/7 availability for patients and health care professionals.

  • Deputy: Finally, many countries also require a deputy LPPV, who acts as a backup when the LPPV is not available.

QPPV and LPPV Services

Through simple and scalable solutions, we provide tiered options and customized services to fit your needs. Contact us to learn more about our QPPV and LPPV services.

Webinar Replay: How to Setup an Effective PV System in the UK and EU/EEA

Watch or re-watch our "QPPV Office: Ensuring Compliance and Safety in Pharmacovigilance" webinar. This session was packed with valuable information on the roles and responsibilities of the Qualified Person for Pharmacovigilance (QPPV), best practices for maintaining compliance, and strategies for ensuring drug safety.

Healthcare professionals in lab coats conversing around a table

QPPV & LPPV Articles

May 30, 2024

The QPPV: An Essential Guide to the Qualified Person Responsible for Pharmacovigilance

The QPPV: An Essential Guide to the Qualified Person Responsible for Pharmacovigilance

When submitting marketing authorisation applications (MAAs) in Europe, the applicant (Marketing Authorization Holder, MAH) shall already have set up a pharmacovigilance system. A Summary of the...

June 6, 2024

The LPPV Network: An Essential Guide to Local Person Responsible for Pharmacovigilance

The LPPV Network: An Essential Guide to Local Person Responsible for Pharmacovigilance

Every marketing authorization holder (MAH) needs a pharmacovigilance system to guarantee the safety of its products.

June 13, 2024

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

The GPO An Essential Guide to the Graduated Plan Officer (Der Stufenplanbeauftragte)

Introduction According to §63a of the German Medicinal Products Act (AMG), a pharmaceutical entrepreneur who places finished medicinal products on the market that are medicinal products within the...

News & Insights

Meet the Expert: Dana E. Vanderwall, PhD.

July 18, 2024

Meet the Expert: Dana E. Vanderwall, PhD.

Meet the Expert: Dana E. Vanderwall, PhD., a Senior Director Digital Transformation at ProPharma, shares insights on PSMF and robust quality management systems.

Regulatory Chemistry, Manufacturing, and Controls (CMC): What to Expect During Drug Development

July 16, 2024

Regulatory Chemistry, Manufacturing, and Controls (CMC): What to Expect During Drug Development

Navigate FDA IND process and discover how CMC sections are integral to drug development to ensure quality, safety, & potency for successful regulatory applications

What is the FSP Model in Clinical Research?

July 15, 2024

What is the FSP Model in Clinical Research?

Discover how the FSP model in clinical research offers flexible, cost-effective outsourcing for specific functions, enhancing drug discovery and trial efficiency.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

News & Insights

ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

May 2, 2024

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma and PBL introduce Cell Factory Box for decentralized Cell & Gene Therapies manufacturing, reducing costs and improving patient access to life-saving treatments.

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

April 18, 2024

ProPharma Now Certified as Medidata Rave EDC Accredited Partner

ProPharma receives Medidata Rave EDC accreditation, enhancing clinical trial efficiency. Learn about the latest milestone delivering cutting-edge solutions.

Previous Post Arrow Next Post Arrow
ProPharma Receives 2024 CRO Leadership Award

June 13, 2024

ProPharma Receives 2024 CRO Leadership Award

ProPharma wins 2024 CRO Leadership Award for exceeding expectations in key categories, solidifying its position as a top global research consulting organization in the life sciences industry.

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

November 27, 2023

EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist

Ernst & Young announces Michael Stomberg as a finalized for Entrepreneur Of The Year® 2023 National Award to celebrate ambitious entrepreneurs.

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

October 11, 2023

ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023

Everest Group has recognized ProPharma Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023.

Previous Award Arrow Next Award Arrow
Meet the Expert: Dana E. Vanderwall, PhD.

July 18, 2024

Meet the Expert: Dana E. Vanderwall, PhD.

Meet the Expert: Dana E. Vanderwall, PhD., a Senior Director Digital Transformation at ProPharma, shares insights on PSMF and robust quality management systems.

Regulatory Chemistry, Manufacturing, and Controls (CMC): What to Expect During Drug Development

July 16, 2024

Regulatory Chemistry, Manufacturing, and Controls (CMC): What to Expect During Drug Development

Navigate FDA IND process and discover how CMC sections are integral to drug development to ensure quality, safety, & potency for successful regulatory applications

What is the FSP Model in Clinical Research?

July 15, 2024

What is the FSP Model in Clinical Research?

Discover how the FSP model in clinical research offers flexible, cost-effective outsourcing for specific functions, enhancing drug discovery and trial efficiency.

Previous Post Arrow Next Post Arrow
Infographic The Cost of Poor Project Management - ProPharma

June 10, 2022

The Cost of Poor Project Management

Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...

Infographic Successfully Passing MHRA Inspections for Overseas Manufacturing Sites - ProPharma

August 31, 2022

Successfully Passing MHRA Inspections for Overseas Manufacturing Sites

ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...

Infographic Navigating the Generic Drug Application and Approval Process - ProPharma

October 4, 2021

Navigating the Generic Drug Application and Approval Process

Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...

Previous Resource Arrow Next Resource Arrow